Association between hepatitis B/C viral infection, chronic kidney disease and insulin resistance in individuals undergoing general health screening

Hepatology Research

Volumn 38, Issue 8, 2008, Pages 775-783

  Ishizaka, Nobukazu ^a   Ishizaka, Yuko ^b   Seki, George ^a   Nagai, Ryozo ^a   Yamakado, Minoru ^b   Koike, Kazuhiko ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b MITSUI MEMORIAL HOSPITAL   (Japan)

Author keywords

Aminotransferase; Chronic kidney disease; Health screening; Insulin resistance; Viral hepatitis

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; GLUCOSE; HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIGEN; INSULIN;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMINURIA; ANTIGEN DETECTION; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; DIET RESTRICTION; DISEASE ASSOCIATION; FASTING BLOOD GLUCOSE; FEMALE; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; HEPATITIS B; HEPATITIS C; HUMAN; INSULIN RESISTANCE; JAPAN; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; PRIORITY JOURNAL;

EID: 47649091714     PISSN: 13866346     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1872-034X.2008.00334.x     Document Type: Article

References (30)

1. Higuchi M, Tanaka E, Kiyosawa K. Epidemiology and clinical aspects on hepatitis C. Jpn J Infect Dis 2002; 55: 69-77.
2. Narai R, Oyama T, Ogawa M et al. HBV- and HCV- infected workers in the Japanese workplace. J Occup Health 2007; 49: 9-16.
3. Yamabe H, Johnson RJ, Gretch DR et al. Hepatitis C virus infection and membranoproliferative glomerulonephritis in Japan. J Am Soc Nephrol 1995; 6: 220-3.
4. El-Serag HB, Hampel H, Yeh C, Rabeneck L. Extrahepatic manifestations of hepatitis C among United States male veterans. Hepatology 2002; 36: 1439-45.
5. Johnson RJ, Couser WG. Hepatitis B infection and renal disease: clinical, immunopathogenetic and therapeutic considerations. Kidney Int 1990; 37: 663-76.
6. Tang S, Lai FM, Lui YH et al. Lamivudine in hepatitis B-associated membranous nephropathy. Kidney Int 2005; 68: 1750-8.
7. Cacoub P, Saadoun D, Bourliere M et al. Hepatitis B virus genotypes and extrahepatic manifestations. J Hepatol 2005; 43: 764-70.
8. Tsui JI, Vittinghoff E, Shlipak MG, O'Hare AM. Relationship between hepatitis C and chronic kidney disease: Results from the Third National Health and Nutrition Examination Survey. J Am Soc Nephrol 2006; 17: 1168-74.
9. Manjunath G, Sarnak MJ, Levey AS. Prediction equations to estimate glomerular filtration rate: An update. Curr Opin Nephrol Hypertens 2001; 10: 785-92.
10. Imai E, Horio M, Nitta K et al. Estimation of glomerular filtration rate by the MDRD study equation modified for Japanese patients with chronic kidney disease. Clin Exp Nephrol 2007; 11: 41-50.
11. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Am J Kidney Dis 2002; 39: S1-266.
12. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998; 15: 539-53.
13. Ishizaka N, Ishizaka Y, Toda E, Nagai R, Yamakado M. Association between serum uric acid, metabolic syndrome, and carotid atherosclerosis in Japanese individuals. Arterioscler Thromb Vasc Biol 2005; 25: 1038-44.
14. Moriya K, Shintani Y, Fujie H et al. Serum lipid profile of patients with genotype 1b hepatitis C viral infection in Japan. Hepatol Res 2003; 25: 371-6.
15. Serfaty L, Andreani T, Giral P, Carbonell N, Chazouilleres O, Poupon R. Hepatitis C virus induced hypobetalipoproteinemia: A possible mechanism for steatosis in chronic hepatitis C. J Hepatol 2001; 34: 428-34.
16. Combes B, Shorey J, Barrera A et al. Glomerulonephritis with deposition of Australia antigen-antibody complexes in glomerular basement membrane. Lancet 1971; 2: 234-7.
17. Huang JF, Chuang WL, Dai CY et al. Viral hepatitis and proteinuria in an area endemic for hepatitis B and C infections: Another chain of link? J Intern Med 2006; 260: 255-62.
18. Tai TY, Lu JY, Chen CL et al. Interferon-alpha reduces insulin resistance and beta-cell secretion in responders among patients with chronic hepatitis B and C. J Endocrinol 2003; 178: 457-65.
19. Shaheen M, Echeverry D, Oblad MG, Montoya MI, Teklehaimanot S, Akhtar AJ. Hepatitis C, metabolic syndrome, and inflammatory markers: Results from the Third National Health and Nutrition Examination Survey [NHANES III]. Diabetes Res Clin Pract 2007; 75: 320-6.
20. Shintani Y, Fujie H, Miyoshi H et al. Hepatitis C virus infection and diabetes: Direct involvement of the virus in the development of insulin resistance. Gastroenterology 2004; 126: 840-8.
21. Koike K. Hepatitis C virus infection can present with metabolic disease by inducing insulin resistance. Intervirology 2006; 49: 51-7.
22. Custro N, Carroccio A, Ganci A et al. Glycemic homeostasis in chronic viral hepatitis and liver cirrhosis. Diabetes Metab 2001; 27: 476-81.
23. Wang CC, Hsu CS, Liu CJ, Kao JH, Chen DS. Association of chronic hepatitis B virus infection with insulin resistance and hepatic steatosis. J Gastroenterol Hepatol 2008; (in press).
24. Niskanen L, Laakso M. Insulin resistance is related to albuminuria in patients with type II (non-insulin-dependent) diabetes mellitus. Metabolism 1993; 42: 1541-5.
25. Jan CF, Chen CJ, Chiu YH et al. A population-based study investigating the association between metabolic syndrome and hepatitis B/C infection (Keelung Community-based Integrated Screening study, 10). Int J Obes (Lond) 2006; 30: 794-9.
26. Luo B, Wang Y, Wang K. Association of metabolic syndrome and hepatitis B infection in a Chinese population. Clin Chim Acta 2007; 380: 238-40.
27. Bonora E, Coscelli C, Orioli S et al. Hyperinsulinemia of chronic active hepatitis: Impaired insulin removal rather than pancreatic hypersecretion. Horm Metab Res 1984; 16: 111-14.
28. Jones GJ, Itri LM. Safety and tolerance of recombinant interferon alfa-2a (Roferon-A) in cancer patients. Cancer 1986; 57: 1709-15.
29. Quesada JR, Talpaz M, Rios A, Kurzrock R, Gutterman JU. Clinical toxicity of interferons in cancer patients: A review. J Clin Oncol 1986; 4: 234-43.
30. Lederer E, Truong L. Unusual glomerular lesion in a patient receiving long-term interferon alpha. Am J Kidney Dis 1992; 20: 516-18.